GLP-1 microdosing plan

The GLP-1 microdosing plan uses a low weekly dose set by your prescribing physician. Follow your prescription label, not a dose found online. “Microdosing” is not a standard medical dosing schedule. Your dose depends on the specific medication, your health history, and your response to treatment.

Use the GLP-1 microdosing plan only as your prescribing physician and pharmacy label direct. The listed schedule is weekly, but your exact dose and method depend on your prescription. Before your first dose, confirm the medication name, dose, supplies, and instructions with your prescriber or pharmacist.

If you miss a GLP-1 microdosing plan dose, follow the missed-dose directions on your pharmacy label or contact your prescribing physician. The right timing depends on the exact medication and how long it has been. Do not double your dose or take doses closer together without clear instructions.

The GLP-1 microdosing plan may cause nausea, vomiting, diarrhea, constipation, or stomach pain, depending on the medication. A low dose does not remove the risk of serious side effects. Seek urgent care for severe or lasting stomach pain, and call 911 for trouble breathing or swelling of the throat.

Yes. Medicines used in the GLP-1 microdosing plan can interact with other treatments. Share all prescriptions, over-the-counter medicines, and supplements with your physician. Insulin and some diabetes drugs can raise the risk of low blood sugar. Do not combine GLP-1 treatments or change other medicines without your prescriber’s guidance.

Store your GLP-1 microdosing plan medication exactly as the pharmacy label directs. Storage rules depend on the drug, formulation, and container. Check whether refrigeration is required and note the discard date after opening. If the medication freezes, gets too warm, or arrives damaged, ask the pharmacy before using it.

There is no established timeline for results with the GLP-1 microdosing plan. “Microdosing” is not a standard medical regimen, and evidence from other GLP-1 doses may not apply. Results vary. Your physician can help define realistic maintenance goals and decide when to review your weight, appetite, and side effects.

Talk with your prescribing physician before stopping the GLP-1 microdosing plan so you have a plan for follow-up and weight care. Appetite or weight may increase after stopping. Results vary. If you have severe symptoms or signs of an allergic reaction, seek urgent care rather than waiting for a routine visit.

A licensed physician in your state must decide whether switching to the GLP-1 microdosing plan is appropriate. Share your current treatment, dose, last dose date, and any side effects. Do not overlap treatments or convert doses yourself. Your new prescription label and prescriber’s instructions must guide the switch.

The current GLP-1 microdosing plan price is shown on the treatment page. Options are monthly, a 3-month plan with 15% off billed monthly, or a 6-month plan with 25% off billed monthly. Medication is charged only after physician approval. The visit fee is separate and non-refundable.

With Verra+, members receive 20% off medications; the current GLP-1 microdosing plan price is shown on the treatment page. Membership costs $29 monthly or $249 annually. Online visits are included for members. Member video visits cost $49. Medication is charged only after a physician approves treatment.

After physician approval, your GLP-1 microdosing plan prescription is dispensed to order and shipped to you. Verra serves all 50 states and DC, though some states or medications require a video visit. Expedited shipping is $20. Check your order details for shipping information; no specific delivery date is guaranteed here.